MAP3K5 and cancer: Additionally, TAT-2GTP1, a cell-permeable derivative of the biotinylated 2GTP1 peptide, selectively disrupts the Trx1–Ask1 interaction that induces phosphorylation and the subsequent activation of ASK1, leading to JNK activation and reduced viability of cancer cells [61].